Recruitment

Recruitment Status
Active, not recruiting
Estimated Enrollment
60

Inclusion Criteria

BMI > 35
BMI > 35

Exclusion Criteria

Ulcus
Hypothyroidism
Dysphagia
...
Ulcus
Hypothyroidism
Dysphagia
Previous cancer in GI-tract
Pregnancy/brest feeding
Previous bariatric surgery
Tendency for aspiration
Known hypersensitivity to medication
Severe eating disorder
Neuro muscular disease
Previous side effects of botox injections
Other obesity treatment last 12 months
Reduced competence to consent
Use of aminoglycoside antibiotics and/or spectinomycin lately

Summary

Conditions
  • Obesity Morbid
  • Obesity, Morbid
Type
Interventional
Phase
Phase 2
Design
  • Allocation: Randomized
  • Intervention Model: Parallel Assignment
  • Masking: Triple (Participant, Care Provider, Outcomes Assessor)
  • Primary Purpose: Treatment

Participation Requirements

Age
Between 18 years and 60 years
Gender
Both males and females

Inclusion Criteria

BMI > 35
BMI > 35

Exclusion Criteria

Ulcus
Hypothyroidism
Dysphagia
...
Ulcus
Hypothyroidism
Dysphagia
Previous cancer in GI-tract
Pregnancy/brest feeding
Previous bariatric surgery
Tendency for aspiration
Known hypersensitivity to medication
Severe eating disorder
Neuro muscular disease
Previous side effects of botox injections
Other obesity treatment last 12 months
Reduced competence to consent
Use of aminoglycoside antibiotics and/or spectinomycin lately

Tracking Information

NCT #
NCT02035397
Collaborators
St. Olavs Hospital
Investigators
  • Principal Investigator: Bård Kulseng, MD, PhD Norwegian University of Science and Technology, Fac MH, IKOM
  • Bård Kulseng, MD, PhD Norwegian University of Science and Technology, Fac MH, IKOM